Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions
Sponsor: National University Hospital, Singapore
Summary
Aim To determine the feasibility and safety of 3 fractions of high dose rate (HDR) brachytherapy with interstitial needles for cervical cancer in the outpatient setting Primary objective To determine the clinical outcome (2-yr local control rate, loco-regional control rate, progression free survival and overall survival) Secondary objective To determine the long-term toxicities of this regimen based on CTCAE v5
Official title: Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions: Dosimetric and Clinical Outcomes
Key Details
Gender
FEMALE
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
56
Start Date
2023-06-26
Completion Date
2026-12
Last Updated
2024-02-28
Healthy Volunteers
No
Conditions
Interventions
3 fractions HDR brachytherapy
The 3 fractions of HDR brachytherapy may be delivered in the following ways: Option 1: 3 insertions over 2 non-consecutive days: Option 2: 3 insertions over 3 non-consecutive days
Locations (1)
National University Hospital
Singapore, Singapore